Chronic Myelogenous Leukemia Presenting as a Secondary Malignancy After BCR-ABL1-negative B-lymphoblastic Leukemia/Lymphoma in a Pediatric Patient

被引：0

作者：

Popa, Gheorghe ^{[1
]}

Blag, Cristina ^{[1
]}

Olteanu, Horatiu ^{[2
]}

机构：

[1] Iuliu Hatieganu Univ Med & Pharm, Pediat Clin 2, Dept Pediat Oncol, Cluj Napoca, Romania

[2] Med Coll Wisconsin, Dept Pathol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA

来源：

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY | 2017年 / 20卷 / 01期

关键词：

chronic myelogenous leukemia; lymphoblastic leukemia/lymphoma; cytogenetics; flow cytometry; BCR-ABLI; CHRONIC MYELOID-LEUKEMIA; CHRONIC GRANULOCYTIC-LEUKEMIA; CHILDREN;

D O I：

10.1177/1093526616671047

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Chronic myelogenous leukemia, BCR-ABL1 positive (CML) is a rare myeloproliferative neoplasm in children and presents even less often as a secondary malignancy in the pediatric population. Below, we report a patient with Philadelphia-negative B-lymphoblastic leukemia/lymphoma, who developed CML several years after achieving complete remission, and summarize the existing literature on the clinical and pathologic features of CML as a secondary pediatric malignancy.

引用

页码：58 / 62

页数：5

共 50 条

[21] Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma [J].

Demiriz, Itir Sirinoglu ;

Tekgunduz, Emre ;

Bozdag, Sinem Civriz ;

Altuntas, Fevzi .

TURKISH JOURNAL OF HEMATOLOGY, 2014, 31 (01) :92-94

[22] Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization [J].

Seong, D ;

Kantarjian, HM ;

Albitar, M ;

Arlinghaus, R ;

Xu, J ;

Talpaz, M ;

Rios, MB ;

Guo, JQ ;

O'Brien, S ;

Siciliano, M .

ANNALS OF ONCOLOGY, 1999, 10 (08) :955-959

[23] Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia A Report of the Association for Molecular Pathology [J].

Jones, Dan ;

Kamel-Reid, Suzanne ;

Bahler, David ;

Dong, Henry ;

Elenitoba-Johnson, Kojo ;

Press, Richard ;

Quigley, Neil ;

Rothberg, Paul ;

Sabath, Dan ;

Viswanatha, David ;

Weck, Karen ;

Zehnder, James .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (01) :4-11

[24] Chronic Myeloid Leukemia as a Secondary Malignancy after Lymphoma in a Child. A Case Report and Review of the Literature [J].

Zahra, Kmira ;

Ben Fredj, Wafa ;

Ben Youssef, Yosra ;

Zaghouani, Houneida ;

Chebchoub, Imene ;

Zaier, Monia ;

Badreddine, Sriha ;

Braham, Nejia ;

Sennana, Hlima ;

Khelif, Abderrahim .

ONKOLOGIE, 2012, 35 (11) :690-693

[25] Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population [J].

Qitian Mu ;

Qiuling Ma ;

Yungui Wang ;

Zhimei Chen ;

Xiangmin Tong ;

Fei-Fei Chen ;

Ying Lu ;

Jie Jin .

Annals of Hematology, 2012, 91 :1065-1072

[26] FIP1L1::PDGFRA Fusion in a Pediatric Patient Presenting With B-Cell Lymphoblastic Leukemia [J].

Nunn, Jenna ;

Williams, Bronwyn ;

Deambrosis, David .

GENES CHROMOSOMES & CANCER, 2025, 64 (02)

[27] Expression of CD25 is a specific and relatively sensitive marker for the Philadelphia chromosome (BCR-ABL1) translocation in pediatric B acute lymphoblastic leukemia [J].

Gaikwad, Amos S. ;

Donohue, Rachel E. ;

Elghetany, M. Tarek ;

Sheehan, Andrea M. ;

Lu, Xinyan Y. ;

Gramatges, Maria M. ;

McClain, Kenneth L. ;

Mistretta, Toni-Ann ;

Punia, Jyotinder N. ;

Moore, Timothy J. ;

Goltsova, Tatiana ;

Cubbage, Michael ;

Curry, Choladda V. .

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09) :6225-6230

[28] Genomic amplification of BCR-ABL1 fusion gene and its impact on the disease progression mechanism in patients with chronic myelogenous leukemia [J].

Chandran, Ramachandran Krishna ;

Geetha, Narayanan ;

Sakthivel, Kunnathur Murugesan ;

Aswathy, Chandran Geetha ;

Gopinath, Preethi ;

Raj, Thampirajan Vimaladevi Akhila ;

Priya, Geetha ;

Nair, Jagathnath Krishna Kumarapillai Mohanan ;

Sreedharan, Hariharan .

GENE, 2019, 686 :85-91

[29] Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion [J].

Wei, Wei ;

Huang, He ;

Zhao, Shan ;

Liu, Wei ;

Liu, Chuan-Xu ;

Chen, Li ;

Li, Jun-Min ;

Wu, Ying-Li ;

Yan, Hua .

APOPTOSIS, 2013, 18 (09) :1060-1070

[30] Prominent hematogone hyperplasia in BCR-ABL1-positive chronic myelogenous leukemia: mimicking recurrent B-lymphoid blast crisis [J].

Horna, Pedro ;

Pantazopoulos, Panagiotis ;

Lancet, Jeffrey E. ;

Moscinski, Lynn C. ;

Zhang, Ling .

LEUKEMIA & LYMPHOMA, 2014, 55 (08) :1952-1954

← 1 2 3 4 5 →